Evan Seigerman, BMO Capital Markets, joins ‘Fast Money’ to talk to Nono Nordisk sinking on guidance cut.
Source link
Trending
- Robinhood’s 175% rally this year is best among U.S. tech stocks
- Brian Niccol turnaround taking hold
- An options strategy to buy the dip on this volatile chipmaker that recently pulled back
- Zuckerberg shares AI superintelligence vision after spending spree
- iPhone maker Foxconn makes a major play for the AI data center
- Microsoft earnings are coming Wednesday. Here’s what top analysts expect
- Trump sets 25% tariff for India plus ‘penalty’ for Russia trade
- At 10 years old, Ethereum’s future is brighter than ever despite recent setbacks
Novo Nordisk needs something new, outside of weigh-loss drugs, says BMO's Seigerman
